1v1 Institutional Counterparty Comparison
Chain Partners vs InBioGen: Regulation, 6D Ratings & Safety Audit
Deterministic head-to-head benchmarking of Chain Partners (Chain Partners) and InBioGen (InBioGen Co Ltd) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.
Coverage: Selected financial institution records: Singapore, Asia-Pacific, the Middle East and emerging markets
Chain Partners and InBioGen are statistically tied in composite 6D scoring (5.0 vs 5.0)
On supervisory breadth, Chain Partners holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s), whereas InBioGen holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s). Allocators should verify the exact licence numbers, domains, and contracting legal entities below before onboarding.
Direct Verification & Supervisory Regulator Dossiers
Cross-check each counterparty's licence status, registered domains, and issuing regulator frameworks.
Chain Partners
0 Regulated · 0 Tier-1Legal reference: Chain Partners
Issuing Regulator Dossiers
No linked regulator dossier in current directory. Browse all regulators →
InBioGen
0 Regulated · 0 Tier-1Legal reference: InBioGen Co Ltd
Issuing Regulator Dossiers
No linked regulator dossier in current directory. Browse all regulators →
6-Dimension Quantitative Scorecard Comparison
Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).
6D Compliance Score Visual Profile (0.0 – 10.0)
| Evaluation Dimension | Methodology Weight | Chain Partners | InBioGen | Score Delta | Dimension Leader |
|---|---|---|---|---|---|
| Overall Composite 6D Score | 100% Composite | 5.0 | 5.0 | 0.0 | Statistical Tie |
| Regulatory & Licensing Integrity | 30% Weight | 5.0 | 5.0 | 0.0 | Statistical Tie |
| Execution & Software Infrastructure | 20% Weight | 1.0 | 3.0 | +2.0 | InBioGen |
| User Reputation & Complaint Telemetry | 20% Weight | 0.0 | 0.0 | 0.0 | Statistical Tie |
| Institutional Brand Longevity | 15% Weight | 5.0 | 5.0 | 0.0 | Statistical Tie |
| Global Market Influence & Footprint | 15% Weight | 5.0 | 5.0 | 0.0 | Statistical Tie |
Visual 6D Compliance Benchmark: Chain Partners vs InBioGen
Vector comparison exhibit contrasting 6-dimension compliance pillars, Tier-1 regulatory authorisations, and exposure telemetry.
Regulatory Standing, Entity & Platform Comparison
Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.
| Audit Attribute | Chain Partners | InBioGen |
|---|---|---|
| Primary Legal Name | Chain Partners | InBioGen Co Ltd |
| Regulatory Risk Standing | Pending Review | Pending Review |
| Active Regulated / Total Filings | 0 regulated / 0 total (0 Tier-1) | 0 regulated / 0 total (0 Tier-1) |
| Supervisory Regulators & Certificates | None on file | None on file |
| Registered Domicile / Address | KR | 14F, 61, Digital-ro 26-gil, Guro-gu, Seoul, Republic of Korea |
| Offered Asset Classes & Services | Multi-asset financial services | Multi-asset financial services |
| Execution Software & Terminals | Proprietary / Web Platform | Proprietary / Web Platform |
| Supported Client Languages | English | English |
| Warning / Exposure Count | 0 recorded warning(s) | 0 recorded warning(s) |
| Direct Licence & Domain Check | Verify Chain Partners → | Verify InBioGen → |
Related Head-to-Head Peer Comparisons
Explore additional institutional matchups involving peers of Chain Partners and InBioGen.
Al Baraka Bank Pakistan vs Chain Partners
Compare side-by-side →Chain Partners vs Industrial Bank
Compare side-by-side →Chain Partners vs Pyypl
Compare side-by-side →Chain Partners vs Keepface
Compare side-by-side →Al Baraka Bank Pakistan vs InBioGen
Compare side-by-side →InBioGen vs Industrial Bank
Compare side-by-side →Frequently Asked Questions: Chain Partners vs InBioGen
Deterministic counterparty comparison answers derived from supervisory records.
Which institution has stronger regulatory oversight: Chain Partners or InBioGen?
Both Chain Partners and InBioGen hold 0 active regulated licence record(s) in our registry. Specifically, Chain Partners maintains 0 recorded filing(s) (none on file) with 0 warning flag(s), whereas InBioGen maintains 0 recorded filing(s) (none on file) with 0 warning flag(s). Always confirm the exact contracting legal subsidiary on the issuing regulator's public register before funding an account.
How do the 6D quantitative compliance scores compare between Chain Partners and InBioGen?
In World Firm Ledger's 6-Dimension scoring matrix (0.0–10.0 scale), Chain Partners records an Overall Score of 5.0 (Risk & Licensing: 5.0, Execution & Software: 1.0, User Reputation: 0.0, Brand Longevity: 5.0, Market Influence: 5.0), compared with InBioGen at 5.0 Overall (Risk & Licensing: 5.0, Execution & Software: 3.0, User Reputation: 0.0, Brand Longevity: 5.0, Market Influence: 5.0).
How do Chain Partners and InBioGen differ in trading platforms and asset classes?
Chain Partners lists multi-asset financial services with execution software [proprietary/web execution], while InBioGen lists multi-asset financial services with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per contracting entity.
How can I verify the licences and official domains of Chain Partners and InBioGen?
Use our dedicated verification lookup pages for Chain Partners (/verify/chain-partners-10181) and InBioGen (/verify/inbiogen) to cross-check recorded licence numbers and registered domains, then confirm the exact entity name, permissions, and approved website URL directly on the issuing regulator's official register. Chain Partners currently carries "Pending Review" standing (0 exposure flag(s)) versus "Pending Review" (0 exposure flag(s)) for InBioGen.
Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.
